SILVER-AMI: Outcomes in Older Persons With Heart Attacks
Launched by YALE UNIVERSITY · Dec 18, 2012
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
The overall objective of this study is to develop and validate risk stratification tools for older adults who have recently had an Acute Myocardial Infarction (AMI). While there is emerging interest in understanding the role of geriatric conditions as they pertain to cardiovascular outcomes, there is no standard, feasible assessment of older patients with AMI that can stratify their risk of subsequent morbidity and mortality. Currently available risk models are designed solely to predict clinical events (e.g. mortality, reinfarction). This is insufficient for shared decision making with old...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥75 years upon admission to the hospital
- • 2. Elevation of cardiac markers within 24 hours of presentation to the hospital
- • a. Troponin must rise above the upper limit of normal established by the hospital as a determinate of cardiac injury.
- 3. Any one of the following:
- • 1. Symptoms of ischemia
- • 2. ECG with ischemic changes
- • 3. Imaging evidence of Infarction
- • 4. Intracoronary thrombus on angiography
- Exclusion Criteria:
- • 1. Patient transferred from another hospital with a length of stay \>48 hours at the referring hospital.
- • 2. Refused Informed Consent
- • 3. Decisional impairment with no legally authorized representative
- • 4. AMI is secondary to chest trauma
- • 5. AMI is secondary to in-patient procedure or surgery
- • 6. History of heart transplant
- • 7. Non-English/Non-Spanish speaking
- • 8. Inability to complete interview (e.g. comatose or aphasia)
- • 9. Inability to contact for follow-up (e.g. no access to phone, not living in the country)
- • 10. Currently a prisoner
- • 11. Death prior to enrollment
- • 12. Previously enrolled in SILVER-AMI
- • 13. Troponin elevation is the result of apical ballooning syndrome (i.e., Takotsubo)
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dearborn, Michigan, United States
Iowa City, Iowa, United States
Providence, Rhode Island, United States
Boston, Massachusetts, United States
Bridgeport, Connecticut, United States
Chicago, Illinois, United States
Boston, Massachusetts, United States
Hackensack, New Jersey, United States
Traverse City, Michigan, United States
Chicago, Illinois, United States
Pittsburgh, Pennsylvania, United States
Torrance, California, United States
Englewood, New Jersey, United States
Winston Salem, North Carolina, United States
Doylestown, Pennsylvania, United States
Ann Arbor, Michigan, United States
New York, New York, United States
Atlanta, Georgia, United States
Winston Salem, North Carolina, United States
Honolulu, Hawaii, United States
Saint Louis, Missouri, United States
Boise, Idaho, United States
Portland, Oregon, United States
Chapel Hill, North Carolina, United States
Aurora, Colorado, United States
Philadelphia, Pennsylvania, United States
Richmond, Virginia, United States
Stockton, California, United States
Grand Rapids, Michigan, United States
Wynnewood, Pennsylvania, United States
Fort Smith, Arkansas, United States
Denver, Colorado, United States
Des Moines, Iowa, United States
Hartford, Connecticut, United States
Rochester, Minnesota, United States
Chicago, Illinois, United States
Minneapolis, Minnesota, United States
Worcester, Massachusetts, United States
Detroit, Michigan, United States
Sacramento, California, United States
Coon Rapids, Minnesota, United States
Evanston, Illinois, United States
Valdosta, Georgia, United States
Santa Barbara, California, United States
Winston Salem, North Carolina, United States
Baton Rouge, Louisiana, United States
New Haven, Connecticut, United States
Missoula, Montana, United States
Albuquerque, New Mexico, United States
Bronx, New York, United States
Norfolk, Virginia, United States
Huntington, West Virginia, United States
Indianapolis, Indiana, United States
Portland, Oregon, United States
Springfield, Missouri, United States
Summit, New Jersey, United States
Sayre, Pennsylvania, United States
Waco, Texas, United States
Fort Wayne, Indiana, United States
Corvallis, Oregon, United States
Tampa, Florida, United States
Milwaukee, Wisconsin, United States
Lynchburg, Virginia, United States
Green Bay, Wisconsin, United States
Oklahoma City, Oklahoma, United States
Los Alamitos, California, United States
Danbury, Connecticut, United States
Macon, Georgia, United States
Hagerstown, Maryland, United States
Boston, Massachusetts, United States
Ann Arbor, Michigan, United States
Okemos, Michigan, United States
Kansas City, Missouri, United States
Lincoln, Nebraska, United States
Omaha, Nebraska, United States
Bridgewater, New Jersey, United States
New York, New York, United States
Roslyn, New York, United States
Stony Brook, New York, United States
Asheville, North Carolina, United States
Fargo, North Dakota, United States
Portland, Oregon, United States
Rapid City, South Dakota, United States
Patients applied
Trial Officials
Sarwat Chaudhry, MD
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials